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Abstract

The potential clinical utility of a novel quantitative electroencephalographic (EEG)-based Brain Function Index (BFI)
as a measure of the presence and severity of functional brain injury was studied as part of an independent prospective
validation trial. The BFI was derived using quantitative EEG (QEEG) features associated with functional brain impairment reflecting current consensus on the physiology of concussive injury. Seven hundred and twenty adult patients
(18–85 years of age) evaluated within 72 h of sustaining a closed head injury were enrolled at 11 U.S. emergency
departments (EDs). Glasgow Coma Scale (GCS) score was 15 in 97%. Standard clinical evaluations were conducted
and 5 to 10 min of EEG acquired from frontal locations. Clinical utility of the BFI was assessed for raw scores and
percentile values. A multinomial logistic regression analysis demonstrated that the odds ratios (computed against
controls) of the mild and moderate functionally impaired groups were significantly different from the odds ratio of the
computed tomography (CT) postive (CT+, structural injury visible on CT) group ( p = 0.0009 and p = 0.0026, respectively). However, no significant differences were observed between the odds ratios of the mild and moderately functionally impaired groups. Analysis of variance (ANOVA) demonstrated significant differences in BFI among normal
(16.8%), mild TBI (mTBI)/concussed with mild or moderate functional impairment, (61.3%), and CT+ (21.9%) patients
( p < 0.0001). Regression slopes of the odds ratios for likelihood of group membership suggest a relationship between
the BFI and severity of impairment. Findings support the BFI as a quantitative marker of brain function impairment,
which scaled with severity of functional impairment in mTBI patients. When integrated into the clinical assessment, the
BFI has the potential to aid in early diagnosis and thereby potential to impact the sequelae of TBI by providing an
objective marker that is available at the point of care, hand-held, non-invasive, and rapid to obtain.
Keywords: brain electrical activity; concussion; ED triage; EEG; functional impairment; mTBI; TBI
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T

raumatic brain injury (TBI) visits to the emergency department (ED) have been reported to have increased by 29%
between 2006 and 20101, whereas overall ED visits only increased
3.6%. This surge likely reflects heightened public awareness of the
potential long-term consequences of TBI and concussion.2 Of the
estimated 4.8 million people evaluated annually in the United
States for TBI,3 approximately 90% are found to be ‘‘mild’’ (mTBI/
concussion)4 by current clinical criteria. Thus the ability to objectively and effectively identify those with mTBI/concussion is of
major public health interest.
There is currently no ‘‘gold standard’’ for the diagnosis of
concussion. More than 20 different published guidelines exist for
grading concussion severity and determining return to activity.
Head impact sensors can provide a warning system of hits, but
readings have not been demonstrated to correlate with or predict
concussion.5 Although advanced neuroimaging has greatly contributed to a better understanding of the pathophysiology of concussion, limited accessibility, relatively long exam times, and
diagnostic imaging expertise limit the clinical utility of such
technologies. Clinical symptom checklists and neurocognitive tests
are used commonly, but the disadvantages include lack of clinical
validation, poor test-retest reliability, and frequent under-reporting
and or exaggeration of symptoms.6
TBI is a complex and heterogeneous disorder, resulting in a
spectrum of associated injury severity. Brain injuries visible on
computed tomography (CT) represent the more severe end of this
pathology spectrum. Advanced functional neuroimaging can detect
brain injuries not visible on CT and have led to a better understanding of injury mechanisms and sequelae of concussive injury.
Changes in ‘‘functional connectivity’’ between regions of the brain
have been demonstrated in diffusion tensor imaging (DTI) studies
providing evidence of the disruption of white matter tract integrity
in concussive injury 7–12 In addition, changes in magnetic resonance spectroscopy (MRS) demonstrate evidence of changes in
brain metabolism as a consequence of concussive injury.13
The physical injuries visible in DTI and MRS images impact the
generation, transmission, and processing of neural signals within
and across regions of the brain that can be measured directly by
encephalography (EEG). This has been observed in studies that
demonstrate a high correlation between DTI/MRS measures and
changes in brain electrical activity, suggesting the utility of such
measures as markers of functional brain injury. In a study comparing DTI and EEG in blast-concussed soldiers, Sponheim and
colleagues14 reported a significant correlation between changes in
mean fractional anisotropy (FA) of four major white matter tracts
related to frontal interhemispheric communication and changes in
phase synchrony of the EEG between frontal and frontotemporal
regions. Another measure of brain electrical activity reported to
reflect brain injury in mTBI/concussion is based on the ‘‘complexity’’ or entropy of the EEG signal, which drops in concussive
injury.15 Changes in the frequency spectra of the EEG, power relationships, and coherence between regions have also been demonstrated in the presence of concussion.16–19
The temporal resolution of brain electrical activity presents an
analytic advantage over other functional neuroimaging methods
including availability at the point of care, ease of use with limited
training, and non-invasive application. This article describes the
development and validation of a novel quantitative EEG-based
Brain Function Index (BFI) to aid in the assessment of mTBI following a head injury. The BFI is derived from those QEEG features
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associated with functional brain impairment reflecting current
consensus on the physiology of concussive injury.11–16 The study
demonstrates potential clinical utility of the BFI in supporting the
evaluation of functional brain injury and the relationship between
the BFI and severity of functional impairment in an independent
prospective validation population.
Methods
Study design and population
The B-Ahead III Validation Triala consisted of a prospective
convenience sample of adult patients presenting to 11 participating
U.S. ED sites.b Patients between the ages of 18 and 85 years who
presented to an ED within 72 h of sustaining a closed head injury,
and who had a Glasgow Coma Scale (GCS) score between 12 and
15 (at the time of the Ahead 300 evaluation) were candidates for
study inclusion.
Patients were excluded if they had scalp lacerations, skull abnormalities, or any other clinical condition that precluded placement
of the electrodes on the forehead in the prescribed locations. Patients
were also excluded if intoxicated to the point where they could not
participate in the study or give informed consent. Patients with advanced dementias, Parkinson’s disease, known chronic drug or alcohol dependence, known seizure disorder or other central nervous
system disorder were also excluded. Other exclusion criteria included history of transient ischemic attack (TIA) or stroke in the past
year, currently receiving dialysis or in end-stage renal disease, active
fever greater than 100F or 37.7C, in critical condition or requiring
advanced airway management, and currently receiving procedural
sedation medications. Patients exhibiting drug/alcohol intoxication
but otherwise satisfying the above criteria were not excluded. Signed
informed written consent, or in a few cases consent by proxy, was
obtained. Assessment of the capacity of the subject to give informed
consent was performed using the Conley criteria.20
Clinical assessments
The evaluation of the study subjects was performed using standard
practice clinical procedures of each ED site. In all cases the determination to receive a CT scan was made by the site ED physician,
according to local standard of care. To address the potential differences between neuro-radiological reads of the CT scans across sites,
independent blinded adjudication was performed by the contract
research organization (CRO; Brain Injury Outcomes [BIOS] Division, Johns Hopkins University). The adjudication followed a rigorous and quantitative procedure involving sequential evaluation by
imaging specialists and physician specialist readers with imagebased initial independent determination of CT+ or CT–, requiring
unanimity for final determinations.21 Evaluation of clinical signs and
symptoms included the Standardized Assessment of Concussion
scale (SAC)22,23 and the Concussion Symptom Inventory (CSI),24
acquired by trained ED personnel.
A categorical classification of functional severity (mild/moderate) was computed for CT negative subjects based on the report of
focal neurological signs, loss of consciousness (LOC), posta
NCT02367300; https://clinicaltrials.gov/ct2/show/NCT02367300?
term=BrainScope&rank=5; accessed June 17, 2016.
b
The 11 ED sites included: Washington University Barnes Jewish
Medical Center, St. Louis, MO; Detroit Receiving Hospital, Detroit, MI;
University of Virginia Health System, Charlottesville, VA; R. Adams
Cowley Shock Trauma Center, Baltimore, MD; Baylor University Medical
Center, Dallas, TX; Emory University/Grady Memorial Hospital, Atlanta,
GA; Wayne State University Sinai-Grace Hospital Detroit, MI; University
of Rochester Medical Center, Rochester, NY; Allegheny General Hospital,
Pittsburgh, PA; University of Texas Memorial Hermann Hospital, Houston, TX; and Hartford Hospital, Hartford, CT.
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traumatic or retrograde amnesia, and the presence and severity of
scores for cognitive function/memory, orientation, headache and
presence of focal neurological signs, and high-risk criteria (e.g.,
persistent vomiting, post-traumatic seizure, GCS score <15) gathered using the above scales.17 Those with focal neurological signs,
or LOC or amnesia and two or more symptoms of moderate to
severe severity (e.g., 4–6 on the Likert scale) were considered
moderate. Those who did not meet criteria for moderate, did not
have focal neurological signs but had altered mental status (AMS)
and at least one concussion symptom or report of LOC or amnesia,
were considered mild. This scoring was performed in a blind retrospective manner performed by the independent CRO (BIOS) and
was used for the characterization of severity of functional impairment only.
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EEG data acquisition
Subjects underwent 5 to 10 min of eyes-closed resting EEG in the
ED. The EEG was recorded using a disposable self-adhesive headset
that positioned electrodes on the standard frontal locations (FP1,
FP2, AFz, F7, and F8) of the expanded International 10/20 system
referenced to linked ears. Electrode impedances were required to be
below 10 kO for data collection. The EEG data were subjected to a
series of artifact detection algorithms that identified and removed any
biological and non-biological contamination, such as that from eye
movement or muscle movement,25 producing a ‘‘clean’’ artifact-free
record of 1 to 2 min required for all further analyses.
Computation of quantitative features of brain electrical
activity EEG (QEEG) for algorithm development
The artifact-free EEG data were subjected to quantitative offline analyses to derive an extensive set of univariate and multivariate features (both linear and non-linear) using advanced signal
processing methods. The univariate feature sets included a broad
range of measures from conventional features derived from power
spectrum estimates in the conventional EEG frequency bands to
non-traditional features based on chaos theory, information theory,
and functional connectivity in the spatiotemporal EEG signal. The
univariate features are age-regressed (where an appropriate age relationship in the normal population is present) and normalized to
standard z-scores. The multivariate features are derived from the
univariate feature z-scores and the formulations are designed to describe changes in brain dynamics across brain regions and across the
EEG frequency bands. See the article by Prichep and associates 25 for
a more complete description of the feature extraction methodology.
Ahead 300 structural injury classification
The likelihood that a patient was CT positive (CT+) was predicted
by the application of the EEG-based structural injury classification
algorithm (Ahead 300 device FDA 510(k) clearance, K161068) described in detail elsewhere.21 This algorithm was independently
developed using a least absolute shrinkage and selection operator
(LASSO) methodology,26 which uses a regularized logistic regression model. The classifier consists of a weighted combination of
selected linear and non-linear QEEG features, enhanced with selected clinical features. The features that are inputs to the algorithm
were selected to optimally reflect traumatic structural brain injury.
The Ahead 300 classification also produced a ternary classification
output implementing a second threshold (T2) which, together with
the binary threshold (T1), defined an equivocal zone (EZ) as a third
classification category. This classifier was demonstrated to obtain
extremely high accuracy for predicting the likelihood of being CT+,
with high negative predictive value (NPV) and sensitivity to any
traumatic bleeding and to hematomas. Specificity was significantly
higher than standard CT decision rules (for details see Hanley and
colleagues21 and Prichep and associates27).
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Analysis
EEG data analysis
Development of the EEG Brain Function Index (BFI).
Two databases were used for development of the BFI, the algorithm
development database (n = 2407) and the healthy volunteer normative database (n = 384). The two databases and the subjects they
represent were mutually independent as well as completely independent from the one used for the validation trial. A brief description of both databases is provided below. Informed consent
was obtained from each subject (each site obtained Institutional
Review Board approval to conduct the study at its site).
The algorithm development database was constructed through
multiple studies across several years of development, under consistent protocols. Study sites included 20 EDs and 11 colleges and high
schools across the United States. Subjects were a convenience
sample (n = 2407; 36% female, 64% male). Of these subjects 29.1%
were controls and 70.9% were TBI patients (29.3% mTBI/concussed
with mild functional impairment, 25.6% mTBI/concussed with
moderate functional impairment, and 16.0% CT+). It is noted that
‘‘controls’’ contained both head-injured normal controls (patients
who sustained a closed head injury but for whom the report of
symptoms/severity indicated normal function) as well as ED controls
with no head injury; TBI patients included males and females between the ages of 15 and 92, who suffered a closed head injury and
had a GCS score of 8 or higher. The mean GCS score of the cohort
was 14.9 (median, 15; standard deviation [SD], 0.4; range, 9–15).
The mean age of the cohort was 39.5 years (median, 36.2; SD, 17.6;
range, 15.1–91.7). The inclusion/exclusion criteria for enrollment
were consistent with those described in the ‘‘Patient Population’’
section for the validation trial.
The healthy volunteer normative database consisted of a total of
384 healthy volunteer subjects (59.6% female; 40.4% male) between
the age of 18 and 85 years, GCS score of 15, and not under duress.
These subjects were recruited from the community surrounding three
clinical sites using a single predefined protocol and assessed for
presence and severity of symptoms using the same clinical assessment tools as used in the current validation population. The mean age
of the cohort was 46.0 years (median, 46.7; SD, 16.4; range, 18.0–
80.8). The inclusion/exclusion criteria for this group included those
described in the ‘‘Patient Population’’ section for the validation trial
with the additional exclusions for subjects with injury above the
clavicle, neck or head injury within the past year, a primary complaint of generalized weakness, a primary complaint of headache or
migraine, a history of brain surgery, TBI, or a history of motor
vehicle accident (MVA) requiring an ED visit within the past year.
With regard to drugs or alcohol, fatigue, pain, and other factors
that may be present in head injury cases, the method used in this
investigation was to include them in all subject groups (controls and
TBI patients), except as defined by exclusion criteria. By doing this,
they are eliminated as differentiating factors between groups, and
features sensitive to these factors are not selected by the classifier,
whereas features independent of such factors that differentiate
between groups are candidates for selection.
The BFI was designed to be an aggregate representation of brain
abnormality that reflects functional impairment in concussive injury.
Based on concussion literature (reviewed above, see Introduction), a
subset of features was identified that have been reported to be reflective of the pathophysiology of concussion. These features include
measures of connectivity between regions of the brain (including
coherence, phase synchrony, power ratios) measures of ‘‘complexity’’
of the EEG signal (including fractal and scale-free dimension), and
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features that relate to changes in the frequency spectra (including
changes in alpha power activity). The formulations were tested on
the algorithm development database in a five-fold cross validation
framework to prevent over-fitting to the data.
BFI computation. The EEG BFI is computed as a linear
combination of the selected subset of the QEEG feature z-scores.
The linear combination includes additional weight assigned to
values that are outside the age-expected normal range for that
feature (to increase the relative contribution of the features with
abnormal values to the index). The general formulation of the index
(Y) for any EEG recording session may be expressed as follows:
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Y

N
¼ wN +i ¼N 1 xi

N
þ wA +i ¼A 1 xi

where, wN is the weight associated with a feature value that is in
the normal range for that feature, NN is the number of features for
the given EEG recording session that are in the normal range, xi is the
value of the ith feature, wA is the weight associated with a feature
value that is outside the normal range, and NA is the number of
features for the given EEG recording session that are outside the
normal range. The normal range of values for any given feature was
computed as the range for a theoretical normally distributed feature
(l = 0, r = 1) within which 80% of the values lie. This normality
requirement translates to an absolute feature z-score value <1.2816
( p < 0.10). This range was computed on the large independent population of healthy volunteer subjects contained in the normative
database. In summary, the computation yields a multivariate combination of those QEEG features (linear and non-linear) that were
most related to the physiology of concussion (based on current
consensus), weighted for each patient by their individual pattern of
significant deviations (relative to normal) for this feature set.
To aid in interpretability, the BFI is expressed as a percentile
relative to the distribution for this measure in the normal (healthy
volunteer) population. In addition to the continuous raw score,
three percentile categories are reported, including: (1) those greater
than or equal to the 10th percentile (within the normal range), (2)
those less than the 10th percentile (1.2816 SDs from the mean of the
normal distribution) but greater than or equal to the 2.5th percentile, and (3) those less than the 2.5th percentile (approximately 2
SDs from the mean of the normal population).
Analysis of trial data. All EEG data processing was completed off-line to maintain data acquisition blind to the clinical
presentation and to blind the classification results at the clinical site.
It is important to note that because the BFI was finalized a priori,
only those specific features used in the BFI computation are extracted from the independent validation population as part of the
BFI calculations. It is also noted that the validation of the BFI was
a secondary end-point of this prospective validation trial. Primary
end-points findings were reported elsewhere.21
Statistical analysis
To statistically demonstrate the scaling of the BFI with increasing
severity of impairment, a multinomial logistic regression28 was
computed for the BFI raw scores and the percentile-based categories (i.e., at or above the 10th percentile, between the 10th percentile and the 2.5th percentile, and below the 2.5th percentile) with
a target alpha of 0.05.
In addition, to assist in illustrating group separation tested in the
multinomial logistic regression analysis, a post hoc Kruskal-Wallis

analysis of variance (ANOVA) was performed to determine if the
mean BFI scores were different for groups of subjects classified by
degree of functional impairment. This non-parametric test was
selected because the assumption of normality for the parametric
ANOVA was not met. Further post hoc analysis using the sensitivity index (d’) is reported to quantify the separation between the
groups.29 Other exploratory analyses were also run to illustrate the
scaling of the BFI with degree of impairment, using histograms
(along with fitted normal distributions), and trends in the probability ratio of group membership.
Results
Characteristics of the validation study population
Seven hundred and twenty (720) closed head-injured subjects
were enrolled in this study. For seven of these subjects, the categorical classification of functional severity could not be computed
due to incomplete symptom information and they were therefore,
dropped from further analysis. The remaining 713 subjects (60.9%
male; 39.1% female) had a mean age of 43.6 years (SD, 18.7;
median, 42.3; range 18–85.6) and a mean GCS score of 14.96 (SD,
0.23; median, 15; range, 12–15). In addition to the CT+ group
(n = 156), the computation of the categorical classification resulted
in two CT negative sub-populations: head-injured normal (patients
who sustained a closed head injury but for whom the report of
symptoms/severity indicated normal function, n = 120) and mTBI/
concussed (mild functional impairment, n = 267 or moderate
functional impairment, n = 170; total n = 437).
Multinomial logistic regression analysis
According to the method of Hosmer and Lemeshow,28 in this
study the odds ratios of the various groups computed against the
head-injured normal group (reference group) were compared by
testing the difference in the slopes of the multi-nomial logistic
regression of the raw BFI scores, b1 (mild with reference), b2
(moderate with reference), and b3 (severe [CT+] with reference).
Alpha inflation was controlled by the Hochberg method.30 The
results of this multinomial logistic regression analysis appears in
Table 1.
As can be seen in Table 1, the BFI score demonstrated statistically significant differences between odds ratios (computed
against the head-injured normal group) of the mild functionally impaired group (CT–, with mild clinical symptomatology)
and the CT+ structural TBI (visible on CT) group, p = 0.0009. It
also demonstrated significant differences in the odds ratios between the moderate functionally impaired group (CT– with
moderate clinical symptomatology) compared with that of the
CT+ structural TBI group, p = 0.0026. A similar analysis with the
percentile-based BFI categories (at or above the 10th percentile,
between the 10th percentile and the 2.5th percentile, and below
the 2.5th percentile) also demonstrated statistically significant
differences between the odds ratios (computed against the headinjured normal group) for the same two comparisons ( p = 0.0017
for mild CT– vs. CT+ TBI to reference and p = 0.0011 for moderate CT– vs. CT+ TBI). This result indicates that the order of the
BFI (raw score and percentile categories) is correlated with the
severity of the functional impairment. No significant differences
in the odds ratios between mild functionally impaired group
compared with that of the moderately functionally impaired group
to the reference group ( p = 0.5120). It is noted that the p-values
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Table 1. Slope Comparisons from the Multinomial
Regression of EEG Brain Function Index Scores
Comparison

Difference
-0.00192
0.00002
-0.00194

b1 vs. b3
b1 vs. b2
b2 vs. b3

Variance
-7

3.78x10
4.44x10-7
4.80x10-7

Z-statistic

P-value

-3.1212
0.0300
-2.8007

0.0009
0.5120
0.0026

b1 refers to the odds ratio comparing mild with reference, b2 refers to
odds ratio comparing moderate with reference, and b3 refers to odds ratios
comparing severe (CT+) with reference group.
CT, computed tomography; EEG, electroencephalographic.

noted correspond to differences in the long odds, which implies
differences in the odds ratios.
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Post hoc analysis
The supporting post hoc non-parametric Kruskal Wallis ANOVA demonstrated that the group means of the three groups (normal,
mTBI/CT–, and CT+) were significantly different. The null hypothesis of equal group means was rejected ( p = 0.001) showing a
statistically significant relationship between BFI score and functional impairment severity. The means and standard errors for the
three groups are shown in Table 2.
The sensitivity index (d’) value for the separation of CT+ group
from the head-injured normal group was computed to be 0.62,
indicating a large degree of separation between the two groups. The
d’ for the separation between the mTBI/concussed and CT+ groups
was computed to be 0.35, which indicates a moderate level of
separation between the groups and supports the ability of the BFI to
distinguish between the two groups. Within the mTBI/concussed
group, the d’ for the separation between mild and moderately
functionally impaired groups was less than 0.1,which indicates a
lack of separation between the two groups.

FIG. 1. Normal distributions fitted to Brain Function Index
(BFI) score to illustrate the BFI increase in response to increasing
severity of brain injury. Frequencies are normalized such that each
histogram has a peak value of 1, and each fitted distribution has a
peak value of 2. CT, computed tomography; mTBI, mild traumatic
brain injury.

shows the group membership odds ratios. The trend lines were
obtained using a second order polynomial regression. The differences in the slopes of the trend lines for the three groups provide
additional support that when the BFI score is greater than 450, a
clear relationship can be seen with TBI severity. That is, as the BFI
score increases (i.e., brain function becomes more abnormal), the
probability of being normal decreases and the probability of being
mTBI/concussed or CT+ increases. It is further noted that the rate
of the increase for the mTBI/concussed group is lesser than that for
the CT+ group.

Relationship of BFI score and severity of impairment
Figure 1 illustrates the distributions of the BFI scores for the
three groups using shifts in a normal distribution fitted to the groupwise BFI histograms. The fitted curves show that the group-wise
BFI distributions shift to the right (increase in BFI) in response to
increasing severity of brain injury.
Figure 2 illustrates the probability ratio analysis of group
membership with increasing BFI severity, where the x axis shows
the BFI score (binned to the nearest hundredths place) and the y axis

Table 2. Group Means, Medians, and Standard Error
for the Three Patient Groups
(Normal, mTBI/CT-, and CT+)
BFI score
Group

N

BFI percentile

Std.
Std.
Mean Median Error Mean Median Error

Normal
120 222.5
mTBI/CT- 437 247.1
CT+
156 299.4

187.5
213.1
247.0

1.0
0.3
1.2

36.2
32.3
27.1

31
24
16

0.2
0.1
0.2

BFI, Brain Function Index; CT, computed tomography; mTBI, mild
traumatic brain injury.

FIG. 2. Trends (regression using second order polynomial fit) in
the probability ratios of group membership for the three subject
groups (normal, mild traumatic brain injury [mTBI]/computed
tomography [CT]–, and CT+). The Brain Function Index (BFI)
scores were binned to the nearest hundreds place (e.g., any score
between 350.00 and 449.99 was placed in a bin with the center at
400). The probability ratio was computed for any bin i as the ratio
of the conditional probability of membership in group j given bin i
to the prior probability of membership in group j.
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Discussion
TBI injuries visible on CT scan represent only a portion of the
full spectrum of TBIs. Although advanced neuroimaging tools have
demonstrated clear abnormalities in mTBI/concussion, such technologies are not readily available in the ED where the CT scan
remains the standard of care for assessing head injury. The importance of early identification of mTBI/concussion is a significant
concern, as untreated concussions can contribute to morbidity with
potentially debilitating and lingering post-concussive symptoms
(including cognitive impairment, development of depression and
anxiety, and somatization disorder).31,32 Additionally, in athletes
there is a higher incidence of repeat concussion following a first
concussion and an increase chance for worse injury if an athlete is
allowed to return to play prior to symptom resolution.33,34 This
head-injured normal validation study demonstrated as a secondary
end-point, the potential clinical utility of the EEG BFI in providing
important quantitative information about the status of brain function in mTBI relative to an uninjured normal population at the
initial point of triage in the emergency setting.
The BFI is derived from advanced signal processing measures
reflective of the physiological changes reported in functional neuroimaging studies of concussion. For example, changes in connectivity reported in TBI using DTI are consistent with phase synchrony
abnormalities reported using QEEG.14 Increasing evidence supports
the use of EEG as a surrogate for conventional neuroimaging, both
reflecting the impact of head injury of neuronal function in the
presence of TBI and concussion. EEG has several advantages, which
include the superior temporal resolution of EEG recordings as well as
the ease of use and availability at the point of care.
In the absence of a ‘‘gold standard’’ for concussion, the BFI
reports results as a percentile relative to a normal healthy volunteer
population, creating a de facto standard aiding in the interpretability of the results. Further, because the use of percentiles is
routine in the reporting of neurocognitive test results, the BFI
percentile can be easily incorporated into a panel of assessment
results that can aid the clinician in reaching the clinical diagnosis of
concussion. This validation study demonstrates an inverse relationship between the severity of symptoms reported (evaluated
taking into consideration both the number and severity of symptoms) and the percentile of the BFI. That is, as the severity increases, the percentile decreases, indicating increased likelihood
of abnormal brain function. It is of interest to note that a post hoc
analysis demonstrated that subjects who were classified as equivocal by the Ahead 300 classifier and had a higher BFI were more
likely to be mTBI than normal.
It was also observed that the sensitivity index (d’) value for the
separation of CT+ patients from the head-injured normal controls
was 0.62, implying a large separation. Although this is to be expected, a CT+ finding (any injury visible on CT in patients with
GCS score = 13–15) does not necessarily mean that the patient is
concussed. In addition, the sensitivity index for the separation between mTBI/concussed and CT+ patients was 0.35, which supports
the ability of the BFI to distinguish between these two groups.
Incidentally, the sensitivity index for the separation between mild
and moderately functionally impaired patients is less than 0.1, indicating a lack of separation. It is important to note that currently,
concussion diagnosis is a clinical determination relying on subjective report of signs and symptoms and there is no consensus on
the predictive nature of these measures. The Ahead 300 device is
cleared by the U.S. Food and Drug Administration (FDA) as an
adjunctive tool and is not expected to be used in isolation, but rather
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as part of a clinical evaluation for the presence of concussion. As
such, this quantitative, objective, multivariate measure can add
information to the evaluation not otherwise available. In addition,
the derivation of the measure adds specificity because the features
included are those most related to the pathophysiology of concussion, especially ‘‘connectivity.’’
Limitations
This study was limited to an adult population. Further studies are
underway to expand into the pediatric population where the objective assessment of mTBI and concussion is greatly needed.
Additionally, clinical sites did not include urgent care or concussion facilities where such capabilities could be clinically important. The analyses in this validation study were conducted off-line.
Future studies need to explore the implementation of the device
into normal patient triage to allow evaluation of the impact of
physicians using such data in real-time acute evaluation individual
mTBI/concussed patients. The lack of significant separation between the patients with mild and moderate functional impairments
suggests the need for further study and perhaps a multi-modal approach to improve this separation.
Conclusion
In this independent validation study, an index based on measures
of brain electrical activity reflective of the physiology of concussion was demonstrated to provide a quantitative index of brain
function impairment in mTBI. The BFI was further demonstrated to
scale with severity of functional impairment in mTBI patients.
These results suggest that the BFI directly addresses the need for an
objective, readily available, assessment of brain function following
head injury, aiding in rapid initial diagnosis and having the potential in the future to provide a quantitative marker for progression
or resolution of mTBI/concussion.
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